These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8137595)

  • 1. Standards for bioequivalence of inhaled products.
    Chrystyn H
    Clin Pharmacokinet; 1994 Jan; 26(1):1-6. PubMed ID: 8137595
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishing bioequivalence for inhaled drugs; weighing the evidence.
    Daley-Yates PT; Parkins DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1297-308. PubMed ID: 21699442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.
    Khoubnasabjafari M; Rahimpour E; Samini M; Jouyban-Gharamaleki V; Chen L; Chen D; Chan HK; Jouyban A
    Daru; 2019 Jun; 27(1):517-524. PubMed ID: 30847847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence of inhaled drugs: fundamentals, challenges and perspectives.
    Apiou-Sbirlea G; Newman S; Fleming J; Siekmeier R; Ehrmann S; Scheuch G; Hochhaus G; Hickey A
    Ther Deliv; 2013 Mar; 4(3):343-67. PubMed ID: 23442081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing bioequivalence for orally inhaled drug products.
    Daley-Yates PT; Parkins DA
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1531-2. PubMed ID: 22004794
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishing bioequivalence for orally inhaled drug products.
    Arieta AG
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1533-4. PubMed ID: 22004795
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.
    Adams WP; Ahrens RC; Chen ML; Christopher D; Chowdhury BA; Conner DP; Dalby R; Fitzgerald K; Hendeles L; Hickey AJ; Hochhaus G; Laube BL; Lucas P; Lee SL; Lyapustina S; Li B; O'Connor D; Parikh N; Parkins DA; Peri P; Pitcairn GR; Riebe M; Roy P; Shah T; Singh GJ; Sharp SS; Suman JD; Weda M; Woodcock J; Yu L
    J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):1-29. PubMed ID: 20131983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample Size Estimation for the U.S. Food and Drug Administration's In Vitro Population Bioequivalence Test of DPIs, MDIs, Nasal Sprays, and Nebules.
    Fuglsang A
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):109-110. PubMed ID: 28880704
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioequivalence assessment of pharmaceutical aerosol products through IVIVC.
    Sandell D
    Adv Drug Deliv Rev; 2021 Sep; 176():113895. PubMed ID: 34329687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report.
    Evans C; Cipolla D; Chesworth T; Agurell E; Ahrens R; Conner D; Dissanayake S; Dolovich M; Doub W; Fuglsang A; García Arieta A; Golden M; Hermann R; Hochhaus G; Holmes S; Lafferty P; Lyapustina S; Nair P; O'Connor D; Parkins D; Peterson I; Reisner C; Sandell D; Singh GJ; Weda M; Watson P
    J Aerosol Med Pulm Drug Deliv; 2012 Jun; 25(3):117-39. PubMed ID: 22413806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of inhaled medications.
    Boyes RN
    Br J Clin Pharmacol; 1992 Oct; 34(4):309. PubMed ID: 1457263
    [No Abstract]   [Full Text] [Related]  

  • 12. In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.
    Forbes B; Bäckman P; Christopher D; Dolovich M; Li BV; Morgan B
    AAPS J; 2015 Jul; 17(4):837-52. PubMed ID: 25940082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of inhaled drugs.
    Derom E; Pauwels R
    Eur Respir J; 1995 Oct; 8(10):1634-6. PubMed ID: 8586113
    [No Abstract]   [Full Text] [Related]  

  • 14. Single Batch Bioequivalence Paradigm for Orally Inhaled Products: Time for Change.
    Hermann R; Olsson B; Borgström L; Sandell D
    Clin Pharmacol Ther; 2018 Mar; 103(3):395. PubMed ID: 29238955
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of comparative performance of orally inhaled drug products in view of the classical bioequivalence paradigms: an analysis of the current scientific and regulatory dilemmas of inhaler evaluation.
    Horhota ST
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):408-13. PubMed ID: 25237840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On sample sizes for bioequivalence studies with inhaled corticosteroids.
    Wijnand HP; de Vos D
    Eur J Clin Pharmacol; 1997; 52(4):325-7, 329-30. PubMed ID: 9248775
    [No Abstract]   [Full Text] [Related]  

  • 17. A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation Approach.
    Weber B; Hochhaus G
    AAPS J; 2015 Jul; 17(4):999-1010. PubMed ID: 25933600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence assessment of inhalation products: Interchangeability, study design and statistical methods.
    Arieta AG
    Pulm Pharmacol Ther; 2010 Jun; 23(3):156-8. PubMed ID: 20064625
    [No Abstract]   [Full Text] [Related]  

  • 20. A European perspective on orally inhaled products: in vitro requirements for a biowaiver.
    García-Arieta A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):419-29. PubMed ID: 25238116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.